Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Amortizatization of Intangibles (2020 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Amortizatization of Intangibles of $470000.0 for Q2 2026, down 51.7% year-over-year from $973000.0 in Q2 2025, and down 11.65% quarter-over-quarter from $532000.0 in Q1 2026.

Amarin Corp Plcuk (AMRN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Amortizatization of Intangibles for 7 consecutive years, with $470000.0 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Amortizatization of Intangibles fell 51.7% year-over-year to $470000.0; the TTM figure through Jun 2026 stood at $2.5 million (down 52.46% YoY), while the FY2025 annual figure was $3.6 million, down 36.36% from the prior year.
  • Amortizatization of Intangibles slipped to $470000.0 in Q2 2026 per AMRN's latest filing, from $532000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.6 million in Q4 2024 and bottomed at -$374000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $755555.6 across 5 years, with a median of $868500.0 in 2023.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 570.65% — and 2025, when it tumbled 59.96%.
  • Amarin Corp Plc\Uk's Amortizatization of Intangibles stood at $284000.0 in 2022, then surged by 291.9% to $1.1 million in 2023, then surged by 40.7% to $1.6 million in 2024, then sank by 59.96% to $627000.0 in 2025, then dropped by 25.04% to $470000.0 in 2026.
  • Business Quant data shows AMRN's Amortizatization of Intangibles at $470000.0 in Q2 2026, $532000.0 in Q1 2026, and $627000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 984.00 Mn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 600.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn 470,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 470,000.00
Jun 30, 2026 470,000.00
Mar 31, 2026 532,000.00
Mar 31, 2026 532,000.00
Dec 31, 2025 627,000.00
Dec 31, 2025 627,000.00
Sep 30, 2025 830,000.00
Sep 30, 2025 830,000.00
Jun 30, 2025 973,000.00
Jun 30, 2025 973,000.00
Mar 31, 2025 1.22 Mn
Mar 31, 2025 1.22 Mn
Dec 31, 2024 1.57 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 1.42 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.20 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.55 Mn
Mar 31, 2024 1.55 Mn